Skip to main content
Log in

Ventriclar Arrhythmias in Patients with Myocardial Infarction and Ischaemia The Role of Serum Potassium

  • Section 3: Electrolyte Changes and the Myocardium: Defining the Risk
  • Published:
Drugs Aims and scope Submit manuscript

Summary

An association between low serum potassium concentrations and ventricular arrhythmias has been observed by a number of investigators in patients with both acute myocardial infarction and symptomatic angina. The increased frequency of ventricular fibrillation in patients with low serum potassium concentrations has not been attributable to differences in the size or location of the infarct or concomitant digitalis administration. Although prior diuretic usage is frequently associated with a low serum potassium concentration, diuretic usage in the absence of significant changes in serum electrolytes is not associated with an increase in malignant ventricular arrhythmias.

It is not clear whether the alterations in serum potassium are important in the pathogenesis of the arrhythmias or merely a marker for other arrhythmogenic factors. To the extent that changes in serum potassium contribute to the production of serious ventricular arrhythmias, efforts should be directed at the correction of such electrolyte disturbances.

Attempts to increase the serum potassium in acute cases do not appear to be successful in preventing ventricular arrhythmias in this setting. Primary prevention of electrolyte disturbances would seem to offer more effective protection against serious arrhythmias. Long term studies with β-blockers support this premise.

Résumé

Nombre d’investigateurs ont trouvé une association entre concentrations sériques de potassium basses et arythmies ventriculaires chez les malades qui présentent un infarctus aigu du myocarde et un angor symptomatique. L’augmentation de fréquence de la fibrillation ventriculaire chez les malades qui ont des concentrations de potassium sérique basses n’a pas été attribuée à des différences de localisation de l’infarctus ou d’administration concomittante de digitaliques. Bien que l’utilisation non contrôlée de diurétiques soit fréquemment associée à un potassium sérique bas, l’emploi de diurétiques en l’absence de modifications significatives des électrolytes sériques n’est pas associée à une augmentation des arythmies ventriculaires malignes.

On ne sait pas clairement si les altérations du potassium sérique sont un facteur important dans la pathologie des arythmies ou simplement un marqueur d’autres facteurs arythmogènes. Dans la mesure où les changements du potassium sérique contribuent à la formation d’arythmies ventriculaires graves, on doit s’efforcer de corriger de tels désordres électrolytiques.

Les tentatives faites pour augmenter le potassium sérique dans les cas aigus ne paraissent pas couronnées de succès pour prévenir les arythmies ventriculaires dans ce contexte. La prévention primaire des désordres électrolytiques semblerait offrir une protection plus efficace contre les arythmies graves. Des études à long terme avec les β bloqueurs étayent cette façon de voir.

Zusammenfassung

Eine Assoziation zwischen niedrigen Serumkonzentrationen von Kalium und ventrikulären Arrhythmien wurde durch eine Anzahl von Untersuchern sowohl bei Patienten mit akutem Myokardinfarkt als auch symptomatischer Angina beobachtet. Die gesteigerte Häufigkeit einer ventrikulären Fibrillation bei Patienten mit niedrigen Kalium-Konzentrationen im Serum wurde auf Unterschiede in der Gröβe oder Lokalisation des Infarkts oder einer gleichzeitigen Gabe von Digitalis zurückgeführt. Obwohl eine vorherige Verwendung von Diuretika häufig mit niedrigen Serumkonzentrationen des Kalium einhergehen, ist eine diuretische Verwendung in Abwesenheit von signifikanten Veränderungen bei den Serum-Elektrolyten nicht mit einem Anstieg von malignen ventrikulären Arrhythmien assoziiert.

Es ist nicht klar, ob die Veränderungen im Serum-Kalium für die Pathogenese der Arrhythmien wichtig oder nur ein Zeichen für andere arrhythmogene Faktoren sind. Falls Veränderungen des Serum-Kalium an der Erzeugung von schweren ventrikulären Arrhythmien beitragen, sollten die Bemühungen auf eine Korrektur solcher Elektrolyt-Störungen gerichtet sein.

Versuche, das Kalium im Serum bei akuten Fällen zu erhöhen, scheinen zur Verhinderung ventrikulärer Arrhythmien unter diesen Umständen nicht erfolgreich zu sein. Eine vorherige Verhinderung von Elektrolyt-Störungen sollte einen wirksameren Schutz gegen schwere Arrhythmien bieten. Langzeitstudien mit Beta-Blockern stützen diese Annahme.

Resumen

Varios investigadores han observado una asociación entre concentraciones bajas de potasio sérico y arritmias ventriculares en pacientes de infarto de miocardio agudo y angor sintomático. La mayor frecuencia de fribilación ventricular en los casos de concentraciones bajas de potasio sérico no ha sido atribuible a diferencias de tamaño o localizacion del infarto ni a la administración concomitante de digital. Aunque el uso previo de diuréticos va unido frecuentemente a una concentración baja de potasio sérico, en su empleo en ausencia de modificaciones significativas de los electrólitos del suero no se asocia a un aumento de las arritmias ventriculares malignas. No está claro si las alteraciones del potasio sérico son importantes en la patogenia de las arritmias o se trata de meros marcadores de otros factores arritmógenos. En la medida en que las modificaciones del potasio sérico contribuyan a laproducción de arritmias ventriculares graves, será preciso esforzarse por corregir dichos trastornos electrolíticos.

Los intentos de aumentar el potasio sérico en los casos agudos no parecen dar resultado para prevenir las arritmias ventriculares en estas condiciones. La prevención primaria de los trastornos electrolíticos parecen ofrecer más protectión efectica contra las arritmias graves. Estudios prolongados con β-bloqueadores respaldan esta afirmación.

Resumo

Foi observada por uma série de investigadores uma associação entre baixas concentrações de potássio no soro e arritmias ventriculares em patientes portadores tanto de enfarto agudo do miocárdio como de angina sintomática. Não se atribui a maior frequência de fibrilação ventricular em patientes com baixas concentrações de potássio no soro a diferenças de tamanho ou localização do enfarto, nem à aplicação concomitante de digital. Embora o uso precedente de diuréticos esteja frequentemente associado a baixas concentrações de potássio no soro, o uso de diuréticos, na ausência de mudanças significativas nos electrólitos no soro, não está associado a urn aumento nas arritmias ventriculares malignas.

Não está claro se as alterações nas concentrações de potássio no soro são importantes na patogênese das arritmias, ou se elas apenas funcionam como sinal de outros fatores arritmogênicos. Contudo, visto que as mudanças nas concentrações de potássio no soro contribuem para a formação de sérias arritmias do ventnículo, deve-se desenvolver esforços no sentido de se corrigir tais distúrbios eletrolíticos.

As tentativas de se aumentar a concentração de potássio no soro em casos agudos não conseguiram prevenir as arritmias do ventrículo num tal quadro. A prevenção primária de distúrbios eletrolíticos parece oferecer proteção mais efetiva contra arritmias graves. Estudos a longo prazo com beta-bloqueadores sustentam esta premissa.

Riassunto

Una associazione tra bassi livelli sierici di potassio e aritmie ventricolari è stata osservata da numerosi ricercatori sia in pazienti con infarto miocardico acuto che con angina sintomatica. Non è stato possibile attribuire l’aumentata frequenza di fibrillazione ventricolare in pazienti con ipopotassiemia a differenze di dimensione o di sede dell’infarto o a contemporanea sontministrazione di digitale. Sebbene un precedente trattamento diuretico sia frequentemente associato ad ipopotassiemia, l’uso di un diuretico in assenza di significative modificazioni di elettroliti sierici, non è associato ad un aumento di aritmie ventricolari maligne. Non è chiaro se le modificazioni del potassio sierico siano importanti nella patogenesi delle aritmie o siano solo un marker di altri fattori aritmogenici. Poichè variazioni del potassio sierico contribuiscono alla produzione di serie aritmie ventricolari, un grande impegno dovrebbe essere diretto alla correzione di tali anomalie elettrolitiche. Tentativi di aumentare il potassio sierico in casi acuti non sembrano efficaci nel prevenire aritmie ventricolari. La prevenzione primaria delle alterazioni elettrolitiche sembrerebbe offrire una protezione più efficace nei confronti delle aritmie gravi. Studi a lungo termine con beta-bloccanti confermano questa tesi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beta-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. Journal of the American Medical Association 247: 1707–1714, 1982

    Article  Google Scholar 

  • Brown MJ, Brown DC, Murray MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. New England Journal of Medicine 309: 1414–1419, 1983

    Article  PubMed  CAS  Google Scholar 

  • Cobb LA, Werner JA, Trobaugh GB. Sudden cardiac death. Modern Concepts of Cardiovascular Disease 49: 31–42, 1980

    PubMed  CAS  Google Scholar 

  • Daniell HW. Arrhythmias in hypokalemia. New England Journal of Medicine 284: 1385, 1974

    Google Scholar 

  • Dyckner T, Helmers C, Lundman T, Wester PO. Initial serum potassium level in relation to early complications and prognosis in patients with acute myocardial infarction. Acta Medica Scandinavica 197: 207–210, 1975

    Article  PubMed  CAS  Google Scholar 

  • Dyckner T, Wester PO. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. American Heart Journal 97: 12–18, 1979

    Article  PubMed  CAS  Google Scholar 

  • Fletcher GF, Hurst JW, Schlant RC. ‘Polarizing’ solutions in patients with acute myocardial infarction. American Heart Journal 75: 319–324, 1968

    Article  PubMed  CAS  Google Scholar 

  • Hulting J. In-hospital ventricular fibrillation and its relation to serum potassium. Acta Medica Scandinavica 647 (Suppl.): 109–116, 1981

    PubMed  CAS  Google Scholar 

  • Johannson BW, Dziamski R. Malignant arrhythmias in acute myocardial infarction: relationship to serum potassium and effect of selective and non-selective β-Blockade. Drugs 28 (Suppl. 1): 77–85, 1984

    Article  Google Scholar 

  • Kannel WB, Gordon T, Castelli WP. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. Annals of Internal Medicine 72: 813–822, 1970

    PubMed  CAS  Google Scholar 

  • Lown B. Sudden cardiac death: the major challenge confronting contemporary cardiology. American Journal of Cardiology 43: 313–328, 1979

    Article  PubMed  CAS  Google Scholar 

  • Medical Research Council Working Party on the Treatment of Myocardial Infarction. Lancet 2: 1355–1360, 1968

    Google Scholar 

  • Mittra B. Potassium, glucose, and insulin in treatment of myocardial infarction. Lancet 2: 607–609, 1965

    Article  PubMed  CAS  Google Scholar 

  • Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results. Journal of the American Medical Association 248: 1465–1477, 1982

    Article  Google Scholar 

  • Nayler WG. The heart cell: some metabolic aspects of cardiac arrhythmias. Acta Medica Scandinavica 647 (Suppl.): 17–31, 1981

    PubMed  CAS  Google Scholar 

  • Nordrehaug JE. Malignant arrhythmias in relation to serum potassium values in patients with an acute myocardial infarction. Acta Medica Scandinavica 647 (Suppl.): 101–107, 1981

    PubMed  CAS  Google Scholar 

  • Nordrehaug JE, Johannessen K, von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 71: 645–649, 1985

    Article  PubMed  CAS  Google Scholar 

  • Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New England Journal of Medicine 304: 801–807, 1981

    Article  Google Scholar 

  • Opie LH, Muller CA, Lubbe WR. Cyclic AMP and arrhythmias revisited. Lancet 2: 921–923, 1978

    Article  PubMed  CAS  Google Scholar 

  • Pentecost BL, Mayne NMC, Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet 1: 946–948, 1968

    Article  PubMed  CAS  Google Scholar 

  • Ramsay LE, Toner JM, Cameron HA. Diuretic use, serum potassium and ventricular fibrillation in patients with myocardial infarction. Proceedings British Pharmacologic Society C26, 1984

  • Reuben SR, Thomas RD. The relationship between serum potassium and cardiac arrhythmias following cardiac infarction in patients aged over 65 years. Current Medical Research Opinion 7 (Suppl.): 79–82, 1982

    CAS  Google Scholar 

  • Reuben SR, VandenBurg MJ, Cooper WD. The influence of prior diuretic therapy on the incidence of early hypokalemia and cardiac arrhythmias following acute myocardial infarction. Presented at the First International Conference on Diuretics, Miami, USA, March, 1984

  • Rogers WJ, Segall PH, McDaniel HG, Mantle JA, Russell RO et al. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. American Journal of Cardiology 43: 801–809, 1979

    Article  PubMed  CAS  Google Scholar 

  • Rolton H, Simpson E, Donnelly T, Rodger JC. Plasma potassium in acute myocardial infarction. European Heart Journal 2 (Suppl.): A21, 1981

    Google Scholar 

  • Rosa RM, Silva P, Young JB, Landsberg L, Brown RS et al. Adrenergic modulation of extrarenal potassium disposal. New England Journal of Medicine 302: 431–434, 1980

    Article  PubMed  CAS  Google Scholar 

  • Ruberman W, Weinblatt E, Goldberg JD, Frank CW, Chaudhary BS et al. Ventricular premature complexes and sudden death after myocardial infarction. Circulation 64: 297–305, 1981

    Article  PubMed  CAS  Google Scholar 

  • Solomon RJ, Cole AG. Importance of potassium in patients with acute myocardial infarction. Acta Medica Scandinavica 647 (Suppl.): 87–93, 1981

    PubMed  CAS  Google Scholar 

  • Steiness E. Diuretics, digitalis and arrhythmias. Acta Medica Scandinavica 647 (Suppl.): 75–78, 1981

    PubMed  CAS  Google Scholar 

  • Struthers AD, Reid JI, Whitesmith MB, Rodger JC. The effect of cardioselective and nonselective beta-adrenoceptor blockade on the hypokalemic and cardiovascular responses to adrenomedullary hormones in man. Clinical Science 65: 143–147, 1983

    PubMed  CAS  Google Scholar 

  • Sundstedt CD, Sylven C, Mogensen L. Glucose-insulin-potassium-albumin infusion in the early phase of acute myocardial infarction. Acta Medica Scandinavica 210: 67–71, 1981

    Article  PubMed  CAS  Google Scholar 

  • Thomas RD. Ventricular fibrillation in myocardial infarction: the role of potassium. Internal Medicine 4 (Suppl.): 7–9, 1983

    Google Scholar 

  • Thompson RG, Cobb LA. Hypokalemia after resuscitation from out-of-hospital ventricular fibrillation. Journal of the American Medical Association 248: 2860–2863, 1982

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solomon, R.J. Ventriclar Arrhythmias in Patients with Myocardial Infarction and Ischaemia The Role of Serum Potassium. Drugs 31 (Suppl 4), 112–120 (1986). https://doi.org/10.2165/00003495-198600314-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198600314-00014

Keywords

Navigation